Previous studies suggest that both CNP and cGMP are capable of regulating GH secretion [22,23], and long-acting CNP analogues are currently in therapeutic use to treat short stature patients, having been shown to improve growth in models of dwarfism and skeletal dysplasias [24,25,26,27]. Here, CNP is linked to Severe short stature.